European Medicines Agency recommends approval of two new treatment options for rare cancers

View source ↗

Summary

EMA recommends approval of two new treatments for rare cancers, expanding options for patients with limited choices.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rare Cancers